Clinical Trial Update: Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate [Phase 4]

View source ↗

Summary

A Phase 4 trial of etanercept in rheumatoid arthritis patients with inadequate response to adalimumab or infliximab plus methotrexate was terminated; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED | Results posted: 2016-01-06